Literature DB >> 26165381

Concurrent Detection of Cellular and Molecular Cancer Markers Using an Immunomagnetic Flow System.

Wanfeng Huang, Chun-Li Chang, Bin-Da Chan, Shadia I Jalal1,2, Daniela E Matei1,2, Philip S Low, Cagri A Savran.   

Abstract

We report a detection system for simultaneous measurement of cellular and molecular markers of cancer. Magnetic beads conjugated with antibodies against a specific antigen are used to capture both free molecules and whole cells overexpressing the antigen. The target-bound beads then flow through a microfluidic chamber where they are drawn to a glass surface by an external magnetic field. The cells and molecules captured on the surface are quantitatively analyzed using fluorescent microscopy. The system was characterized by detecting free folate receptor (FR) and an FR+ cancer cell line (KB) in culture media. The system detected as low as 10 pM of FR and captured 87% of the spiked KB cells at a volumetric throughput of 3 mL/min. We further demonstrated the detection of 100 KB cells and 200 pM FR spiked into healthy human blood to simulate detection of rare cells and protein biomarkers present in a cancer patient's blood sample. The FR concentration was measured to be 244 pM (including the intrinsic FR present in the blood), and the total number of KB cells in the sample was estimated to be 98. The potential of this approach in clinical diagnostics was also demonstrated by detecting both FR+ cells and free FR in an ascites sample obtained from an ovarian cancer patient. Because of the system's capability to detect multiple targets at the same time, its high throughput, and its overall simplicity, we expect it to be highly useful in a wide range of research settings.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26165381     DOI: 10.1021/acs.analchem.5b02215

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  4 in total

1.  The Role of Microsystems Integration Towards Point-of-Care Clozapine Treatment Monitoring in Schizophrenia.

Authors:  Thomas E Winkler; Florence O Stevenson; Eunkyoung Kim; Mijeong Kang; Gregory F Payne; Deanna L Kelly; Reza Ghodssi
Journal:  IEEE Sens Lett       Date:  2017-12-13

2.  Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial.

Authors:  Milan Radovich; Guanglong Jiang; Bradley A Hancock; Christopher Chitambar; Rita Nanda; Carla Falkson; Filipa C Lynce; Christopher Gallagher; Claudine Isaacs; Marcelo Blaya; Elisavet Paplomata; Radhika Walling; Karen Daily; Reshma Mahtani; Michael A Thompson; Robert Graham; Maureen E Cooper; Dean C Pavlick; Lee A Albacker; Jeffrey Gregg; Jeffrey P Solzak; Yu-Hsiang Chen; Casey L Bales; Erica Cantor; Fei Shen; Anna Maria V Storniolo; Sunil Badve; Tarah J Ballinger; Chun-Li Chang; Yuan Zhong; Cagri Savran; Kathy D Miller; Bryan P Schneider
Journal:  JAMA Oncol       Date:  2020-09-01       Impact factor: 31.777

3.  Magnetized carbon nanotubes for visual detection of proteins directly in whole blood.

Authors:  Yan Huang; Yongqiang Wen; Kwaku Baryeh; Sunitha Takalkar; Michelle Lund; Xueji Zhang; Guodong Liu
Journal:  Anal Chim Acta       Date:  2017-09-27       Impact factor: 6.558

4.  Magnetic micro/nanoparticle flocculation-based signal amplification for biosensing.

Authors:  Omary Mzava; Zehra Taş; Kutay İçöz
Journal:  Int J Nanomedicine       Date:  2016-06-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.